A detailed history of Pinpoint Asset Management LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Pinpoint Asset Management LTD holds 4,050 shares of LLY stock, worth $3.22 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
4,050
Previous 3,209 26.21%
Holding current value
$3.22 Million
Previous $2.91 Million 23.51%
% of portfolio
0.91%
Previous 0.57%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $649,369 - $807,376
841 Added 26.21%
4,050 $3.59 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $179,042 - $224,532
247 Added 8.34%
3,209 $2.91 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $1.75 Million - $2.35 Million
2,962 New
2,962 $2.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pinpoint Asset Management LTD Portfolio

Follow Pinpoint Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinpoint Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinpoint Asset Management LTD with notifications on news.